Effect of anticoagulant therapy in COVID-19 patients.

ABSTRACT:

Background

In patients hospitalised with COVID-19, an increased incidence of thromboembolic events, such as pulmonary embolism, deep vein thrombosis and stroke, has been reported. It is unknown whether anticoagulation can prevent these complications and improve outcome.

Methods

A systematic literature search was performed to answer the question: What is the effect of (prophylactic and therapeutic dose) anticoagulation therapy in COVID-19 patients on cardiovascular and thromboembolic complications and clinical outcome? Relevant outcome measures were mortality (crucial), hospital admission, length of stay, thromboembolic complications (pulmonary embolism, stroke, transient ischaemic attack), need for mechanical ventilation, acute kidney injury and use of renal replacement ther

SUBMITTER: Tieleman RG 

PROVIDER: S-EPMC8050812 | biostudies-literature | 2021 May

REPOSITORIES: biostudies-literature